Reabilitação na Esclerose Lateral Amiotrofica: revisão da literatura

Autores

  • Denise Rodrigues Xerez Hospital Universitário Clementino Fraga Filho

DOI:

https://doi.org/10.11606/issn.2317-0190.v15i3a102947

Palavras-chave:

Esclerose Amiotrófica Lateral, Reabilitação, Literatura de Revisão como Assunto

Resumo

A Esclerose Lateral Amiotrófica é uma patologia do Neurônio Motor que traz um grande grau de incapacidade. Em todo o mundo existe uma tendência a elaborar manuais de uniformização na abordagem desta população, principalmente no que se refere à reabilitação e qualidade de vida. Levantamos os guidelines publicados para este fim, de maneira não sistemática estrita, e elaboramos a partir destes, uma proposta de manual adaptado a realidade brasileira, atualizado, abrangente e simples.

Downloads

Os dados de download ainda não estão disponíveis.

Referências

Dubrovsky AL, Sica RE. Current treatment pathways in ALS: a South American perspective. Neurology. 1999;53(8 Suppl 5):S11-6.

Cronin S, Hardiman O, Traynor BJ.Ethnic variation in the incidence of ALS: a systematic review. Neurology. 2007;68(13):1002-7.

Bradley WG, Anderson F, Bromberg M, Gutmann L, Harati Y, Ross M, et al. Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology. 2001;57(3):500-4.

Bertorini TE, editor. Clinical evaluation and diagnostic tests for neuromuscular disorders. Woburn: Butterworth-Heinemann; 2002.

Kimura F, Fujimura C, Ishida S, Nakajima H, Furutama D, Uehara H, et al. Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS. Neurology. 2006;66(2):265-7.

Kaufmann P, Levy G, Thompson JL, Delbene ML, Battista V, Gordon PH, et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology. 2005;64(1):38-43.

Xerez DR, Rocha PGO, Aguiar CA, Saadi LMV. Profile of the population yhat underwent chemical neurolysis with botulim toxin type A in a Brasilian PM&R Universitary center between 2002-2007 [p441]. J Rehabil Med. 2008;40(Suppl 47):271-2. [Presented at 16th European Congress of Physical Medicine and Rehabilitation Medicine; 2008; Brugge, Belgium.

Smithson WH.Integrating the algorithm into community practice. Neurology. 1999;53(8 Suppl 5):S63-6.

Van den Berg JP, Kalmijn S, Lindeman E, Veldink JH, de Visser M, Van der Graaff MM, et al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology. 2005;65(8):1264-7.

Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology. 1999;52(7):1311-23.

Bryson HM, Fulton B, Benfield P. Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis. Drugs. 1996;52(4):549-63.

Hyson H, Johnson AM, Jog MS. Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study. Mov Disord. 2002;17(6):1318-20.

Verma A, Steele J. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis. Muscle Nerve. 2006;34(2):235-7.

Newall AR, Orser R, Hunt M. The control of oral secretions in bulbar ALS/MND. J Neurol Sci. 1996;139 Suppl:43-4.

Gallagher JP. Pathologic laughter and crying in ALS: a search for their origin. Acta Neurol Scand. 1989;80(2):114-7.

Brooks BR, Thisted RA, Appel SH, Bradley WG, Olney RK, Berg JE, et al. Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: a randomized trial. Neurology. 2004;63(8):1364-70.

Diener HC, Dethlefsen U, Dethlefsen-Gruber S, Verbeek P. Effectiveness of quinine in treating muscle cramps: a double-blind, placebo-controlled, parallel-group, multicentre trial. Int J Clin Pract. 2002;56(4):243-6.

Borasio GD, Voltz R, Miller RG. Palliative care in amyotrophic lateral sclerosis. Neurol Clin. 2001;19(4):829-47.

Publicado

2008-09-09

Edição

Seção

Artigo de Revisão

Como Citar

1.
Reabilitação na Esclerose Lateral Amiotrofica: revisão da literatura. Acta Fisiátr. [Internet]. 9º de setembro de 2008 [citado 28º de março de 2024];15(3):182-8. Disponível em: https://www.revistas.usp.br/actafisiatrica/article/view/102947